resources

Webinar: Bridging the IVIVC Gap for Subcutaneous Biologics

Webinar: Bridging the IVIVC Gap for Subcutaneous Biologics

Webinar

Preview - This content has been restricted to logged in users only.

Explore in-vitro models and predictive tools to assess subcutaneous bioavailability, improve IVIVC, and accelerate monoclonal antibody development.
Webinar: Bridging the IVIVC Gap for Subcutaneous Biologics

Webinar

Predicting subcutaneous (SC) bioavailability of monoclonal antibodies presents unique challenges. This webinar explores emerging in-vitro tools, including the SCISSOR system and skin-on-chip models, alongside predictive modeling and cross-industry collaboration to improve in-vitro–in-vivo correlations (IVIVC), reduce clinical development risk, and accelerate the development of high-dose, high-volume subcutaneous biotherapeutics.

‍

Previous post